Document is current
Any future updates will be listed below
-
Authors
Bean, Stephanie
Dhanda, Rahul https://orcid.org/0000-0002-6941-3853
Graham, Christina A.
Hoffman, Deborah
Rodriguez-Lee, Mariam
Ionescu, Adrian
Karantzoulis, Stella
Kennedy, Sidney H.
Rizvi, Sakina J.
- License Information
-
More Information
Article History
Received: 2 May 2024
Accepted: 2 March 2025
First Online: 11 March 2025
Declarations
:
: This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and are consistent with Good Clinical Practice and applicable regulatory requirements. This study was conducted in accordance with the regulations of the US FDA as described in 21 CFR 50 and 56, applicable laws, and Institutional Review Board requirements. Participant consent was obtained prior to performing any study-related procedures, including screening.
: By signing the informed consent form, participants consented to publication of their deidentified data.
: Stephanie Bean was previously an employee of IQVIA, which was contracted by Neurocrine Biosciences, Inc. to conduct this study. Rahul Dhanda was previously an employee of Neurocrine Biosciences, Inc. Christina A Graham is an employee of IQVIA, which was contracted by Neurocrine Biosciences, Inc. to conduct this study. Deborah Hoffman was an employee of Takeda Pharmaceutical Company. Mariam Rodriguez-Lee is an employee of Neurocrine Biosciences, Inc. Adrian Ionescu is an employee of Neurocrine Biosciences, Inc. Stella Karantzoulis is an employee of IQVIA, which was contracted by Neurocrine Biosciences, Inc. to conduct this study. Sidney H Kennedy has received funding for consulting or speaking engagements from Abbvie, Boehringer-Ingelheim, Janssen, Lundbeck, Lundbeck Institute, Merck, Otsuka, Pfizer, Sunovion, and Servier. He has received research support from Abbott, Brain Canada, Canadian Institutes of Health Research, Janssen, Lundbeck, Neurocrine, Ontario Brain Institute, Otsuka, Pfizer, and Canada’s Strategy for Patient-Oriented Research. He has stock/stock options in Field Trip Health. Sakina J Rizvi has received research funding/consultancy fees from the following sources: Allergan Canada, Brain and Behavior Foundation, Canadian Institute for Health Research, Ontario Brain Institute, Canadian Biomarker Integration Network for Depression, Janssen, Labbatt Family Network, Neurocrine, Pfizer Canada, Providence Healthcare Foundation, Research Innovation Council (SMH). She also holds the copyright for the DARS.
